Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap6.71B
Enterprise Value6.2B
P/E Ratio18.3
PEG Ratio0.18
Price/Sales Ratio4.47
Price/Book Ratio1.84
Enterprise/Revenue4.11
Enterprise/EBITDA15.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.25
Operating Margin0.24
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.1

Income Statement

Revenue1.06B
Revenue/Share3.8
Gross Profit762.92M
EBITDA231.92M
Net Income244.37M
Diluted EPS0.76

Balance Sheet

Total Cash1.48B
Total Cash/Share4.67
Total Debt143.12M
Total Debt/Equity0.05
Current Ratio4.67
Book Value Per Share9.44

Price History

52-Week Change-21.39
52-Week High28
52-Week Low17.1
Moving Average 50 Days20
Moving Average 200 Days21.9

Statistics

Average Volume514,161
Shares Outstanding310.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.31
Trailing Annual Dividend Yield1.77
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD